Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA10
- Pharmacological subgroupA10B
- Chemical subgroupA10BH
- Chemical substanceA10BH04Alogliptin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- ATC code
- A10BH04
- ATC group
- Alimentary tract and metabolism
- Registers
- 7
- Historical lists
- 1
- Registrations
- 80
- With their own page
- 47
- Companies
- 17
All medicines with Alogliptin
Human medicines from every register that match Alogliptin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
80 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| benzoato de alogliptina | Brazil | Authorised | Eurofarma Laboratorios S.A. | ||
| benzoato de alogliptina | Brazil | Authorised | Brainfarma Indústria Química e Farmacêutica S.A | ||
| benzoato de alogliptina | Brazil | Authorised | Althaia S.A. Industria Farmaceutica | ||
| cloridrato de metformina + benzoato de alogliptinaCombination | Brazil | Authorised | Brainfarma Indústria Química e Farmacêutica S.A | ||
| cloridrato de metformina + benzoato de alogliptinaCombination | Brazil | Authorised | Makrofarma Quimica Farmaceutica Ltda | ||
| cloridrato de metformina + benzoato de alogliptinaCombination | Brazil | Authorised | Sanusphar Pesquisa e Desenvovimento Ltda | ||
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | Brazil | Authorised | Makrofarma Quimica Farmaceutica Ltda | ||
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | Brazil | Authorised | Brainfarma Indústria Química e Farmacêutica S.A | ||
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | Brazil | Authorised | Sanusphar Pesquisa e Desenvovimento Ltda | ||
| KazanoCombination | United States | 12.5MG BASE; 1GM, 12.5MG BASE; 500MG | tablet | Marketed | Takeda Pharms USA |
| Nesina | United States | 12.5MG BASE, 25MG BASE, 6.25MG BASE | tablet | Marketed | Takeda Pharms USA |
| OseniCombination | United States | 12.5MG BASE; 15MG BASE, 12.5MG BASE; 30MG BASE, 12.5MG BASE; 45MG BASE … | tablet | Marketed | Takeda Pharms USA |
| IncresyncCombination | European Union | Authorised | Takeda Pharma A/S | ||
| Incresync 12,5 mg/30 mg comprimidos recubiertos con peliculaCombination | Spain | 12,5 mg + 30 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Incresync 25 mg/30 mg comprimidos recubiertos con peliculaCombination | Spain | 25 mg + 30 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| VipdometCombination | European Union | Authorised | Takeda Pharma A/S | ||
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/850 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 850 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/850 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 850 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/850 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 12,5 mg + 850 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipidia | European Union | Authorised | Takeda Pharma A/S | ||
| Vipidia 12,5 MG Comprimidos Recubiertos con Pelicula | Spain | 12,5 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipidia 25 MG Comprimidos Recubiertos con Pelicula | Spain | 25 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |